Editorial

Pediatric Obesity Pharmacotherapy

JAMA 10.1001/jama.2026.22895

November 15, 2026 at 6:00 PM EST

Read the full article

Check out the JAMA Network ObesityWeek 2026 collection

JAMA Network is publishing two clinical trials and its fourth JAMA Summit Report at ObesityWeek.

Sunday, November 15

Once-Weekly Ribupatide for Weight Loss in Adults in China With Overweight or Obesity (JAMA Original Investigation; meeting presentation)

Tirzepatide in Adolescents With Obesity (JAMA Original Investigation; meeting presentation; see related commentary)

Tale of Two Estimands (JAMA Editor's Note)

Monday, November 16

Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss (JAMA Research Letter; timed to coincide with meeting)

Tuesday, November 17

Toward a Healthier Future Through Obesity Prevention and Care (JAMA Special Communication; meeting presentation)

Corresponding Author: William J. Heerman, MD, MPH, Vanderbilt Health, 2146 Belcourt Ave, Nashville, TN 37209 (bill.heerman@vumc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.22895

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks